SKI Market

A+| A| A-|

Indian Indices

Sensex

77,569.39 827.57
( 1.08%)

Global Indices

Nasdaq

52,658.24 149.83
(0.29%)

Dow Jones

7,594.79 30.15
(0.40%)

Hang Seng

68,634.11 890.26
(1.31%)

Nikkei 225

10,498.02 25.57
(0.24%)

Forex

USD-INR

95.45 -0.01
(-0.01%)

EUR-INR

109.10 0.17
(0.15%)

GBP-INR

127.94 0.35
(0.28%)

JPY-INR

0.59 0.00
(0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sandu Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524703

INE751D01014

36.3372594

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

22.4

39.61

EPS(TTM)

Face Value()

Div & Yield %

1.83

2.44

Back

Digicontent reports consolidated net loss of Rs 7.28 crore in the December 2025 quarter

Jan 29,2026

Net loss of Digicontent reported to Rs 7.28 crore in the quarter ended December 2025 as against net profit of Rs 6.59 crore during the previous quarter ended December 2024. Sales rose 17.04% to Rs 128.14 crore in the quarter ended December 2025 as against Rs 109.48 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	128.14	109.48	17
OPM %	8.20	12.52	-
PBDT	9.18	11.99	-23
PBT	7.21	9.95	-28
NP	-7.28	6.59	PL

77,569.39 827.57 ( 1.08%)

52,658.24 149.83 (0.29%)

7,594.79 30.15 (0.40%)

68,634.11 890.26 (1.31%)

10,498.02 25.57 (0.24%)

95.45 -0.01 (-0.01%)

109.10 0.17 (0.15%)

127.94 0.35 (0.28%)

0.59 0.00 (0.03%)